Particulate matter (PM) is a ubiquitous air pollutant that is a growing public health concern. Previous studies have suggested that PM is associated with asthma development and exacerbation of asthma symptoms. Although several studies have suggested increased risks of atopic dermatitis, allergic rhinitis, and allergic sensitization in relation to PM exposure, the evidence remains inconsistent. The plausible mechanisms underlying these effects are related to oxidative stress, enhancement of sensitization to allergens, inflammatory and immunological responses, and epigenetics. This review discusses the effect of PM on childhood allergic diseases, along with plausible mechanisms. Further studies are required to understand the role of PM exposure on childhood allergic diseases, to reduce these diseases in children.
Introduction
Air pollution has been suggested as an important environmental risk factor for allergic diseases. Among air pollutants, particulate matter (PM) is a growing public health concern. PM is a complex and heterogeneous mixture of tiny solid or liquid particles suspended in a gas 1) that is generated from fossil fuel combustion by road transport and power plants; industrial processes, such as the production of metals, cement, lime, and chemicals; construction work; cigarette smoking; and wood stove burning. 1) PM contains acids, organic chemicals, hydro carbons, metals, and biological material (e.g., endotoxins, allergens, and pollens). 13) PM is categorized according to its aerodynamic diameter: PM 10 (smaller than 10 μm), coarse PM (ranging from 2.5 to 10 μm), PM 2.5 (smaller than 2.5 μm), and ultrafine PM (smaller than 0.1 μm) 2) Several studies have investigated the relationship between allergic diseases and PM.
In this review, we discuss the effects of PM on childhood allergic diseases and the possible mechanisms. 14) In a populationbased birth cohort study, an increased risk of asthma incidence (up to age 14-16 years) was associated with increased exposure to PM 2.5 absorbance at the birth address, but not at the current address. 15) There were also no significant associations between PM 2.5 absorbance and asthma prevalence in that study. 15) A British birth cohort study showed that asthma prevalence from birth to 11 years of age was not associated with PM 10 exposure during the first year of life and throughout the lifetime. 16) Further, a metaanalysis of crosssectional studies conducted in 12 European countries showed no association between PM 10 and asthma pre valence. 17) The European Study of Cohorts for Air Pollution Effects project found no significant association between PM exposure and asthma prevalence in 5 European birth cohorts. 18) The reasons for these differing results among epidemiologic studies may arise from differences in exposure and outcome measurement, study pop ulation, and study design.
Association of PM and childhood allergic diseases in epidemiologic studies

2) Asthma exacerbation (Table 2)
Several studies have reported an association between increased PM levels and the exacerbation of asthmarelated symptoms, with hyperresponsiveness at the age of 7 years in children with a family history of asthma. 9) In a systematic review, prenatal exposure to PM 10 was found to be significantly related to asthma development (OR, Other cohort studies have not found a significant association between PM and asthma incidence. For example, a Canadian cohort study found that PM 10 exposure during pregnancy increased asthma onset in young children (age <6 years: adjusted OR [aOR], 1.12; 95% CI, 1.05-1.19), whereas it did not affect schoolaged children (age ≥6 years: aOR, 1.09; 95% CI, 0.96-1.24).
12) Moreover, PM 2.5 and PM 10 exposure during the first year of life and the first 3 years of life were not associated with childhood asthma onset in Latino and African American populations. 13) In a cohort of 2,497 children in kindergarten and first grade in the US, newonset asthma was not associated with PM 2.5 and PM 10 during 3 years of followup. ) resulted in an increase of 2.4% in asthmarelated hospitalization among child ren aged 0-14 years. 19 ) PM 10 was also found to increase the risk of asthmarelated hospitalization (aOR, 1.02; 95% CI, 1.01-1.04) in a nested case-control study of children aged 3-18 years in France. 20) An observational timeseries analysis in the US showed a 26% increase in intensive care unit admissions and a 19% increase in general hospitalizations for each 12μg/m 3 increase in PM 2.5 .
21) The
InnerCity Asthma Study in the US revealed that higher PM 2.5 is associated with significantly lower forced expiratory volume in 1 second and peak expiratory flow (PEF) in children with moderate tosevere asthma. 22) A metaanalysis revealed a significant associa tion between PM 2.5 levels and moderate or severe exacerbation of asthma (OR, 1.022; 95% CI, 1.000-1.045). 23) Another metaanalysis
showed that a significant relationship exists between exposure to PM10 (aOR, 1.013; 95% CI, 1.008-1.018) and PM 2.5 (aOR, 1.025; 95% CI, 1.013-1.037),with increased emergency room visits and hospital admissions. 24) Another metaanalysis found that an increase of 10 μg/m 3 in PM 10 increases asthma symptoms by 2.8% and de creases PEF by 0.082 L/min. 25) 2. Allergic rhinitis (Table 3) The role of PM in childhood allergic rhinitis (AR) is not well est ablished. Although some epidemiologic studies suggest increased risks of AR in relation to PM exposure, the evidence remains in con sistent. Different AR definitions, exposure assessments, and study designs might explain these inconsistent results. In a cross sectional study of 2,661 kindergarten children in Taiwan, lifetime PM 2.5 exposure increased the risk of lifetime AR (OR, 1.54; 95% CI, 1.03-2.32). 26) Annual mean exposure to PM 10 (OR, 1.16; 95% CI, 1.04-1.28) and PM 2.5 (OR, 1.38; 95% CI, 1.08-1.78) was associated with current AR in children aged 8-9 years, in a crosssectional study in England. 27) Another crosssectional study in France showed that the 3year average concentration of PM 10 (OR, 1.20; 95% CI, 1.01-1.44) was associated with increased lifetime AR in children aged 9-11 years. 28) A cohort study of 2,598 children aged 3-6 years in China showed that PM 10 exposure during the first year of life increased lifetime AR (OR, 1.54; 95% CI, 1.07-2.21). 29) A pooled metaanalysis of 6 birth cohorts showed a significant association between PM 2.5 exposure at the birth address and AR at the age of 7-8 years (OR, 1.37 per 5 μg/m 3 PM 2.5 ). 30) Some studies have reported no association between PM and 36) and another longitudinal study among 41 children aged 8-12 years in Korea found that pruritus severity was significantly associated with ultrafine PM. 37) There is little evidence on the association between PM exposure and AD prevalence and incidence, and the available results are inconsistent. Further research is needed to investigate the impact of PM on AD prevalence and incidence. One study showed that the 3year average concentration of PM 10 43) China PM 10 During pregnancy Not associated with AD incidence at the age of 3-6 years PM, particulate matter; AD, allergic dermatitis; OR, odds ratio; CI, confidence interval.
prenatal period and 3 months after birth was not asso ciated with AD at the age of 6 months in a Taiwan birth cohort study. 42) Finally, a prospective cohort study in China showed that PM 10 exposure during pregnancy was not associated with AD incidence in children aged 3-6 years. 43) 4. Allergic sensitization (Table 5) The association between PM and allergic sensitization is not well established due to the inconsistent results across studies. Pollen sen sitization was significantly associated with 3year average concen tration of PM 10 (OR, 1.35; 95% CI, 1.09-1.68) in a crosssectional study among French children aged 9-11 years. 28) A pop ulation based study including children aged 9-10 years in Oslo did not show a significant association between PM 10 exposure in the first year of life or lifetime PM 10 exposure and sensitization to any allergen. 44) However, PM 2.5 during the first 6 years of life increased sensitization to any inhalant (OR, 1.45; 95% CI, 1.21-1.74) and pollen (OR, 1.52; 95% CI, 1.23-1.87) at the age of 6 years in a Ger man birth cohort study. 41) In a Dutch birth cohort study, PM 2.5 exposure at the birth address was associated with sensitization to food allergens at the age of 4 years but not at 8 years; associations between sensitization and inhalant allergens were not significant at either 4 or 8 years. 4, 45) A Swedish birth cohort study also found no clear associations between PM 10 exposure during the first year of life and overall sen sitization at the age of 4 and 8 years. 46) A metaanalysis of 5 Euro pean birth cohorts showed no clear associations between PM 2.5 and PM 10 exposure and allergic sensitization in children up to 10 years of age. 47) Finally, another metaanalysis of birth cohort studies reported significant associations between early childhood PM 2.5 exposure and sensitization to outdoor aero aller gens but not indoor aeroallergens.
48)
Mechanisms
The mechanisms by which PM induces effects on childhood al lergic diseases remain unclear. Oxidative stress and damage, en hance ment of sensitization to allergens, inflammatory pathways and immunological responses, and epigenetics may have roles in childhood allergic diseases caused by PM. The plausible mechanisms by which PM affects childhood allergic diseases are summarized in Fig. 1. 
Oxidative stress and damage
PM forms reactive oxygen species (ROS), such as superoxide anion, hydrogen peroxide, and hydroxyl radicals.
2) These ROS may directly damage proteins, lipids, and DNA. 49) For example, ROS mo difies surfactant protein, which enhances lipid peroxidation, inflam ma tion, and oxidative damage within the lung. Lipid peroxidation, or the oxidative degeneration of lipids, can damage cell membranes and can ultimately lead to cell death. In addition, an endproduct 
Epigenetics
Epigenetic changes may play a role in regulating the expression of genes related to allergic diseases. Exposure to ambient polycyclic aromatic hydrocarbons during pregnancy is associated with in creased DNA methylation of the acylcoenzyme A synthetase long chain family member 3 promoter in cord blood DNA and is related to increased asthma risk in children. 54) Increased air pollution is also associated with hypermethylation of the FOXP3 gene in the peripheral blood of children with asthma, impairing regulator Tcell function and increasing asthma morbidity.
55)
Prenatal exposure to PM
PM can act directly through translocation via the placenta or indirectly by compromising placental function. 56) Transplacental exposure to PMinduced oxidative stress and byproducts of PM metabolism damage DNA, alter gene function, and subsequently affect fetal development. 56) Prenatal PM exposure may also influence immune programming. One study showed that increased PM 2.5 levels during 14 days prior to birth was associated with decreased levels of T lymphocytes and increased B lymphocytes in cord blood. 57) Higher prenatal PM 10 exposure decreased the expression of cytokines IL10 and IL1β and increased the percentage of CD4+ CD25+Tcells in cord blood. 58, 59) Higher exposures to PM 2.5 during midpregnancy were found associated with a higher pre valence of elevated cord IgE. 60) Increased levels of ROS, placental inflammation, maternal blood viscosity, and endothelial dysfunction could be associated with inadequate placental perfusion, which would sub sequently impair transplacental oxygen and nutrient exchange and consequently affect fetal development.
56,61)
Conclusions
There is considerable evidence that PM is an important risk fac tor in childhood allergic diseases. Oxidative stress, enhanced sensi tization to allergens, inflammatory and immunological responses, and epigenetics are considered possible mechanisms. PM exposure during the prenatal period may also affect childhood allergic dis ease by way of direct transplacental exposure or possibly by compro mising placental function. Further studies are needed to identify the mechanisms by which PM causes allergic diseases and to identify factors that increase the susceptibility of children to PM and allergic diseases, such as genetic polymorphisms and critical exposure windows. Effective new preventive and therapeutic approaches are also needed. Precise exposure assessments, as well as biomarkers of exposure and health effects, are required to accurately evaluate the association between PM and childhood allergic diseases. Strict monitoring and avoidance of PM exposure, as well as new clinical and therapeutic strategies, could helpto prevent childhood allergic diseases.
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